Unknown PHASE3 INTERVENTIONAL 2-arm NCT04010669

The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver Resection

The Effect of Somatostatin in the Regulation of Velocity and Blood Flow of the Hepatic Circulation in Patients Undergoing Liver Resection

Sponsor: Laikο General Hospital, Athens

Conditions Portal Hypertension

Interventions Placebo Somatostatin

Updated 5 times since 2019 Last updated: Jul 4, 2019 Started: Aug 1, 2019 Primary completion: Mar 31, 2020 Completion: Jul 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04010669, this PHASE3 trial focuses on Portal Hypertension and remains ongoing. Sponsored by Laikο General Hospital, Athens, it has been updated 5 times since 2019, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting PHASE3
Aug 2019 — Jan 2021 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Laikο General Hospital, Athens

Data source: Laikο General Hospital, Athens

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.